228 related articles for article (PubMed ID: 31756387)
1. Structure and function of USP5: Insight into physiological and pathophysiological roles.
Ning F; Xin H; Liu J; Lv C; Xu X; Wang M; Wang Y; Zhang W; Zhang X
Pharmacol Res; 2020 Jul; 157():104557. PubMed ID: 31756387
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
Wang S; Juan J; Zhang Z; Du Y; Xu Y; Tong J; Cao B; Moran MF; Zeng Y; Mao X
Cell Death Dis; 2017 Sep; 8(9):e3058. PubMed ID: 28933784
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.
Dayal S; Sparks A; Jacob J; Allende-Vega N; Lane DP; Saville MK
J Biol Chem; 2009 Feb; 284(8):5030-41. PubMed ID: 19098288
[TBL] [Abstract][Full Text] [Related]
4. USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila.
Ristic G; Tsou WL; Guzi E; Kanack AJ; Scaglione KM; Todi SV
J Biol Chem; 2016 Apr; 291(17):9161-72. PubMed ID: 26917723
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain.
Mann MK; Franzoni I; de Freitas RF; Tempel W; Houliston S; Smith L; Vedadi M; Arrowsmith CH; Harding RJ; Schapira M
J Med Chem; 2019 Nov; 62(22):10144-10155. PubMed ID: 31663737
[TBL] [Abstract][Full Text] [Related]
6. USP5: Comprehensive insights into structure, function, biological and disease-related implications, and emerging therapeutic opportunities.
Gao ST; Xin X; Wang ZY; Hu YY; Feng Q
Mol Cell Probes; 2024 Feb; 73():101944. PubMed ID: 38049041
[TBL] [Abstract][Full Text] [Related]
7. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu FE; Ventii KH; Wilkinson KD
Annu Rev Biochem; 2009; 78():363-97. PubMed ID: 19489724
[TBL] [Abstract][Full Text] [Related]
8. Vialinin A is a ubiquitin-specific peptidase inhibitor.
Okada K; Ye YQ; Taniguchi K; Yoshida A; Akiyama T; Yoshioka Y; Onose J; Koshino H; Takahashi S; Yajima A; Abe N; Yajima S
Bioorg Med Chem Lett; 2013 Aug; 23(15):4328-31. PubMed ID: 23791076
[TBL] [Abstract][Full Text] [Related]
9. Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway.
Potu H; Peterson LF; Pal A; Verhaegen M; Cao J; Talpaz M; Donato NJ
Oncotarget; 2014 Jul; 5(14):5559-69. PubMed ID: 24980819
[TBL] [Abstract][Full Text] [Related]
10. Two ZnF-UBP domains in isopeptidase T (USP5).
Avvakumov GV; Walker JR; Xue S; Allali-Hassani A; Asinas A; Nair UB; Fang X; Zuo X; Wang YX; Wilkinson KD; Dhe-Paganon S
Biochemistry; 2012 Feb; 51(6):1188-98. PubMed ID: 22283393
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship of USP5 Inhibitors.
Mann MK; Zepeda-Velázquez CA; González-Álvarez H; Dong A; Kiyota T; Aman AM; Loppnau P; Li Y; Wilson B; Arrowsmith CH; Al-Awar R; Harding RJ; Schapira M
J Med Chem; 2021 Oct; 64(20):15017-15036. PubMed ID: 34648286
[TBL] [Abstract][Full Text] [Related]
12. Structure-based virtual screening of novel USP5 inhibitors targeting the zinc finger ubiquitin-binding domain.
Wang T; Tong J; Zhang X; Wang Z; Xu L; Pan P; Hou T
Comput Biol Med; 2024 May; 174():108397. PubMed ID: 38603896
[TBL] [Abstract][Full Text] [Related]
13. Method for the Purification of Endogenous Unanchored Polyubiquitin Chains.
Scott D; Strachan J; Krishna VG; Shaw B; Tooth DJ; Searle MS; Oldham NJ; Layfield R
Methods Mol Biol; 2016; 1449():203-13. PubMed ID: 27613037
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into interactions between ubiquitin specific protease 5 and its polyubiquitin substrates by mass spectrometry and ion mobility spectrometry.
Scott D; Layfield R; Oldham NJ
Protein Sci; 2015 Aug; 24(8):1257-63. PubMed ID: 25970461
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitylases USP5 and USP13 are recruited to and regulate heat-induced stress granules through their deubiquitylating activities.
Xie X; Matsumoto S; Endo A; Fukushima T; Kawahara H; Saeki Y; Komada M
J Cell Sci; 2018 Apr; 131(8):. PubMed ID: 29567855
[TBL] [Abstract][Full Text] [Related]
16. USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α.
Huang W; Liu X; Zhang Y; Deng M; Li G; Chen G; Yu L; Jin L; Liu T; Wang Y; Chen Y
J Cell Physiol; 2022 Apr; 237(4):2211-2219. PubMed ID: 35102545
[TBL] [Abstract][Full Text] [Related]
17. A Linear Diubiquitin-Based Probe for Efficient and Selective Detection of the Deubiquitinating Enzyme OTULIN.
Weber A; Elliott PR; Pinto-Fernandez A; Bonham S; Kessler BM; Komander D; El Oualid F; Krappmann D
Cell Chem Biol; 2017 Oct; 24(10):1299-1313.e7. PubMed ID: 28919039
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.
Li J; Li H; Zhu W; Zhou B; Ying J; Wu J; Zhang H; Sun H; Gao S
J Cell Mol Med; 2020 Jan; 24(2):1370-1382. PubMed ID: 31845546
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of deubiquitinating enzyme inhibitors.
Colland F
Biochem Soc Trans; 2010 Feb; 38(Pt 1):137-43. PubMed ID: 20074048
[TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis of the role of USP5 in human cancers.
Yan B; Guo J; Deng S; Chen D; Huang M
Sci Rep; 2023 Jun; 13(1):8972. PubMed ID: 37268697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
